Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2005
10/18/2005US6955883 Life sciences business systems and methods
10/18/2005US6955878 Apparatus for analyzing samples using linear probe array
10/18/2005US6955872 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics
10/18/2005US6955855 Fluorescence; overcoating using reaction product of imidazole and phosphine compound
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005US6955787 Integrated biological and chemical sensors
10/18/2005US6955751 Light-controlled electrokinetic assembly of particles near surfaces
10/18/2005US6955652 Non-invasive, miniature, breath monitoring apparatus
10/18/2005US6955650 Metabolic calorimeter employing respiratory gas analysis
10/18/2005US6955625 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/18/2005US6955462 Mixing chamber
10/18/2005US6955120 Pressure control system for printing a viscous material
10/18/2005US6955099 Spill proof liquid sample cup
10/18/2005CA2391302C Method and apparatus for reducing peak broadening associated with the establishment of an electric field
10/18/2005CA2382143C Method, reagent and test cartridge for determining clotting time
10/18/2005CA2333614C Method of unsupervised cell nuclei segmentation
10/18/2005CA2299504C Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
10/18/2005CA2195794C Device for measuring the permeability of rock fragments
10/18/2005CA2184386C Interference eliminating agent for application in immunoassays
10/18/2005CA2143999C Device and method for combined bioaffinity assay and electrophoretic separation
10/18/2005CA2006929C Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
10/16/2005CA2464786A1 Residential potable water test
10/14/2005CA2504092A1 Method and device for the detection of sf6 decomposition products
10/14/2005CA2503849A1 Spectroscopic method and apparatus for analyte measurement
10/14/2005CA2464181A1 Controlled dilution system for drinking water and unit therefor
10/13/2005WO2005095991A1 Addressable chem/bio chip array
10/13/2005WO2005095990A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 52 (gpr52)
10/13/2005WO2005095989A1 Diagnostics and therapeutics for diseases associated with endothelin receptor type a (ednra)
10/13/2005WO2005095988A2 Selection of bacterial inner-membrane anchor polypeptides
10/13/2005WO2005095987A2 Salivary soluble cd44: a molecular marker for head and neck cancer
10/13/2005WO2005095986A2 New method
10/13/2005WO2005095985A1 Diagnostics and therapeutics for diseases associated with endothelin type b receptor-like protein 2 (etbr-lp-2)
10/13/2005WO2005095984A2 Diagnostics and therapeutics for diseases associated with g protein-coupled alpha 2a-adrenoceptor (adra2a)
10/13/2005WO2005095983A1 Diagnostics and therapeutics for diseases associated with protein kinase c, gamma (prkcg)
10/13/2005WO2005095982A1 Solid support systems for the homogeneous detection of interactions of biomolecules without washing steps
10/13/2005WO2005095981A1 Cancer diagnosis and treatment using anti-robo1 antibody
10/13/2005WO2005095980A1 Death-associated protein kinase (dap-kinase) as a new marker for breast cancer prognosis
10/13/2005WO2005095979A1 Use of protein proc as a marker for colorectal cancer
10/13/2005WO2005095978A1 Pyrroline-5-carboxylate reductase as a marker for colorectal concer
10/13/2005WO2005095977A1 Diagnostics and therapeutics for diseases associated with p21/cdc42/rac1-activated kinase 1 (pak1)
10/13/2005WO2005095976A1 Diagnostics and therapeutics for diseases associated with p21 (cdkn1a)-activated kinase 3 (pak3)
10/13/2005WO2005095975A2 Anti-fungal target genes
10/13/2005WO2005095974A1 Differentiation assay for aiv infected birds
10/13/2005WO2005095973A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54)
10/13/2005WO2005095972A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor etb (etb)
10/13/2005WO2005095971A1 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 9 (map3k9)
10/13/2005WO2005095970A1 Method of examining rheumatoid arthritis and examination kit
10/13/2005WO2005095969A1 Magnetic particle with reactive dye linked thereto and method of protein separation and purification
10/13/2005WO2005095968A1 Sensing tool
10/13/2005WO2005095967A1 Hybrid phase lateral flow assay
10/13/2005WO2005095966A1 Immobilization vehicle, method of treating vehicle and continuous vehicle treating apparatus
10/13/2005WO2005095965A1 Analytical platform and method for generating protein expression profiles of cell populations
10/13/2005WO2005095964A2 Methods and compositions for the detection of cervical disease
10/13/2005WO2005095963A2 Sensor array integrated circuits
10/13/2005WO2005095962A1 Method for immobilizing polypeptides and solid supports having polypeptides immobilized thereon
10/13/2005WO2005095961A1 Process for producing biochip, probe solution, and biochip
10/13/2005WO2005095960A1 Use of a composition which regulates regulates oxidation/reduction reactions intracellularly and/or extracellularly in a staining or sorting process of spermatozoa
10/13/2005WO2005095959A2 Methods for treating dermatological conditions in a patient
10/13/2005WO2005095958A1 Assay method of identifying candidate for drug
10/13/2005WO2005095957A1 Assays system for specific inhibitors of protein kinase c-related kinases
10/13/2005WO2005095956A2 Diagnostics and therapeutics for diseases associated with megakaryocyte-associated tyrosine-protein kinase
10/13/2005WO2005095955A1 Screening for lysosomal storage disease status
10/13/2005WO2005095954A1 A filter for separating blood-corpuscles and plasma from blood, and blood analysis system using this filter
10/13/2005WO2005095953A2 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 6 (ccr6)
10/13/2005WO2005095952A1 System and method for simulating lubricating oil testing
10/13/2005WO2005095951A1 Method for evaluating bonding strength of roughened surface of copper foil
10/13/2005WO2005095950A1 Method and device for evaluation of pharmaceutical compositions
10/13/2005WO2005095949A1 Method and apparatus for monitoring catalytic abator efficiency
10/13/2005WO2005095942A1 Method of analyzing biosample by laser ablation and apparatus therefor
10/13/2005WO2005095941A1 Mass analysis method using fine metal particles
10/13/2005WO2005095924A1 A sensor for measuring gas permeability of a test material
10/13/2005WO2005095646A2 Episomal expression system
10/13/2005WO2005095645A1 Sequential intracellular screening method
10/13/2005WO2005095643A1 Pdk4 as marker for ppardelta modulation
10/13/2005WO2005095641A1 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 11 (map3k11)
10/13/2005WO2005095639A1 Method of multiquantification for cholesterol of low-density lipoprotein
10/13/2005WO2005095638A2 A kit for measuring the thrombin generation in a sample of a patient’s blood or plasma
10/13/2005WO2005095637A1 Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 beta (mlk4 beta)
10/13/2005WO2005095636A2 Methods for measuring enzyme activities in cells, blood, tumors and tissues
10/13/2005WO2005095635A1 Food borne pathogen sensor and method
10/13/2005WO2005095633A1 A cell culture system for modelling serum amyloid a amyloidogenesis and identifying amyloid modulating compounds
10/13/2005WO2005095632A2 Methods for identifying proteins with starch phosphorylating enzymatic activity
10/13/2005WO2005095631A2 Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 alpha (mlk4 alpha)
10/13/2005WO2005095630A2 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 10 (map3k10)
10/13/2005WO2005095612A1 Gene encoding guanine nucleotide exchange factor and gene product thereof
10/13/2005WO2005095610A1 Nucleic acid expressed in the hypothalamus or muscle tissue and uses thereof in diagnoses
10/13/2005WO2005095609A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide
10/13/2005WO2005095604A1 Rf rp transgenic animal
10/13/2005WO2005095603A1 Detection instrument with the use of polynucleotides mapped on barley chromosome
10/13/2005WO2005095598A1 Cancer antigen peptide originating in wt1
10/13/2005WO2005095587A1 Process for producing somatic stem cell differentiated from embryonic stem cell and use of the same
10/13/2005WO2005095510A1 Thermoresponsive polymer composition and uses thereof
10/13/2005WO2005095461A2 Gold-binding protein and use thereof
10/13/2005WO2005095459A2 Monoclonal antibodies to gastrin hormone
10/13/2005WO2005095458A1 CHIMERIC MONOCLONAL ANTIBODY FOR BINDING WITH HIGH AFFINITY SELECTIVELY TO hCG
10/13/2005WO2005095457A2 Immunoglobulins
10/13/2005WO2005095455A1 Antibody specific for parafibromin, a new marker of parathyroid carcinoma
10/13/2005WO2005095454A1 Lng105 antibody composition and methods of use, and use of lng105 to assess lung cancer risk
10/13/2005WO2005095452A1 Calcium ion leakage inhibitors
10/13/2005WO2005095262A1 Microchip and method for detecting molecules and molecular interactions
1 ... 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 ... 3937